KIDRON NADAV bought ORMP
January 22, 2026 · Form 4 insider transaction
KIDRON NADAV bought 109,000 shares of Oramed Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 7 days after the transaction.
Direction
Acquired (buy-side)
Shares
109,000
Price
$0.00
Total value
N/A
InsiderKIDRON NADAV
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 22, 2026
Filing dateJanuary 29, 2026
Shares owned after3,355,238
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the vesting of performance stock units ("PSUs") granted to the Reporting Person on December 31, 2025, which vested on January 22, 2026, upon the Issuer's common stock, par value $0.012 per share ("Common Stock"), achieving a specified price per share. The shares of Common Stock were received for no consideration upon such vesting.